In AML with NPM1 mutations, NPM1–FOXM1 complex sequesters FOXM1 in the cytoplasm and confers favorable treatment outcomes for AML patients because of FOXM1 inactivation. The gene discussed is NPM1; the disease is acute myeloid leukemia.